We are live on ! Find out more
GMED icon

Globus Medical

450 hedge funds and large institutions have $7.72B invested in Globus Medical in 2024 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 136 increasing their positions, 167 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

416% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $3.12M

38% more funds holding in top 10

Funds holding in top 10: 1622 (+6)

27% more capital invested

Capital invested by funds: $6.08B → $7.72B (+$1.64B)

25% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 55

3% more funds holding

Funds holding: 439450 (+11)

0.32% less ownership

Funds ownership: 100.41%100.09% (-0.32%)

19% less repeat investments, than reductions

Existing positions increased: 136 | Existing positions reduced: 167

Holders
450
Holders Change
+11
Holders Change %
+2.51%
% of All Funds
6.5%
Holding in Top 10
22
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+37.5%
% of All Funds
0.32%
New
69
Increased
136
Reduced
167
Closed
55
Calls
$16.1M
Puts
$3.12M
Net Calls
+$13M
Net Calls Change
+$3.82M
Name Holding Trade Value Shares
Change
Change in
Stake
Commonwealth Equity Services
276
Commonwealth Equity Services
Massachusetts
$468K -$142K -2,382 -26%
CCA
277
Conservest Capital Advisors
Pennsylvania
$467K
M&T Bank
278
M&T Bank
New York
$457K -$7.83K -131 -2%
HSBC Holdings
279
HSBC Holdings
United Kingdom
$454K +$69.5K +1,163 +21%
SA
280
Sanctuary Advisors
Indiana
$451K +$533K +8,923 New
YMRC
281
Yorktown Management & Research Company
Virginia
$438K -$173K -2,900 -31%
CAM
282
Cresset Asset Management
Illinois
$433K -$27.5K -461 -7%
Creative Planning
283
Creative Planning
Kansas
$422K +$52.9K +886 +17%
CCM
284
Coldstream Capital Management
Washington
$417K -$3.82K -64 -1%
URS
285
Utah Retirement Systems
Utah
$411K -$29.9K -500 -8%
RFC
286
Regions Financial Corp
Alabama
$409K -$4.12K -69 -1%
TRCT
287
Tower Research Capital (TRC)
New York
$407K +$42.2K +707 +14%
WAM
288
Weatherly Asset Management
California
$393K -$12.9K -216 -4%
ProShare Advisors
289
ProShare Advisors
Maryland
$382K -$18.6K -311 -5%
HA
290
Hanover Advisors
South Carolina
$382K
Wealth Enhancement Advisory Services
291
Wealth Enhancement Advisory Services
Minnesota
$376K +$36.4K +609 +12%
MFIM
292
Mesirow Financial Investment Management
Illinois
$367K
IIM
293
INTECH Investment Management
Florida
$359K +$313K +5,247 New
PP
294
Paloma Partners
Connecticut
$357K +$312K +5,217 New
HWAM
295
Hennion & Walsh Asset Management
New Jersey
$356K -$2.87K -48 -0.9%
II
296
Inspire Investing
Idaho
$350K -$91.2K -1,526 -23%
RC
297
RBF Capital
California
$342K
Cetera Investment Advisers
298
Cetera Investment Advisers
Illinois
$330K -$69.8K -1,169 -20%
Los Angeles Capital Management
299
Los Angeles Capital Management
California
$323K
GT
300
Greenleaf Trust
Michigan
$314K +$1.37K +23 +0.5%

GMED Hedge Fund Activity: Q2 2024 in Review

450 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2024, worth a combined $7.72B — up 27% from $6.08B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new GMED positions and 55 closed out — a net gain of 14 holders — while 136 added to existing stakes and 167 trimmed.

The largest buyer was Select Equity Group, opening a new position worth an estimated $80M. The largest seller was Dimensional Fund Advisors, cutting an estimated $57.1M.

  • 450 institutional investors held Globus Medical (GMED) as of Q2 2024, up from 439 in Q1 2024.
  • Funds reported $7.72B of Globus Medical stock for Q2 2024, up 27% quarter-over-quarter.
  • 69 funds opened new Globus Medical positions in Q2 2024 and 55 closed out, a net change of +14 holders.
  • The largest Globus Medical buyer in Q2 2024 was Select Equity Group, an estimated $80M added.
  • The largest Globus Medical seller in Q2 2024 was Dimensional Fund Advisors, an estimated $57.1M sold.

Based on aggregated 13F filings for Q2 2024.